[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-372000-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-372000-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","redox-active-nitroxides-enhance-cisplatin-efficacy-against-cervical-cancer","Redox-active nitroxides enhance cisplatin efficacy against cervical cancer","","Cisplatin remains the primary treatment for most cervical cancer cases, but its clinical efficacy is limited by dose-dependent toxicity and the development of chemoresistance. Glucocorticoid receptor overexpression and the cellular redox state are linked to resistance. This study evaluates steroidal and nitroxide-based treatment combinations to improve cisplatin efficacy in cervical cancer. Two nitroxide-functionalised prednisolone hybrids (CS91, CS187) show strong anti-proliferative activity and preserved GR binding. Together with cisplatin, they reduce cell viability in a dose-dependent manner, increase intracellular ROS, lower glutathione, and elevate DNA damage, producing synergistic effects compared with cisplatin alone.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/redox-active-nitroxides-enhance-cisplatin-efficacy-against-cervical-cancer/372000/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/redox-active-nitroxides-enhance-cisplatin-efficacy-against-cervical-cancer/372000.png","ImageObject",300,407,{"name":42,"@type":43},"anakgang17","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is cisplatin less effective in cervical cancer over time?","Question",{"text":63,"@type":64},"Cisplatin efficacy is hindered by dose-dependent toxicity and chemoresistance. Resistance is associated with factors such as altered uptake, target changes, improved DNA repair or detoxification via elevated cellular thiols like glutathione, and links to glucocorticoid receptor overexpression and cellular redox state.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are CS91 and CS187 in this study?",{"text":68,"@type":64},"CS91 and CS187 are two nitroxide-functionalised prednisolone hybrid lead compounds. They show potent anti-proliferative activity across multiple cervical squamous cell carcinoma cell lines while maintaining glucocorticoid receptor binding capability.",{"name":70,"@type":61,"acceptedAnswer":71},"How do CS91/CS187 improve cisplatin effects mechanistically?",{"text":72,"@type":64},"Mechanistic work indicates these compounds raise intracellular reactive oxygen species levels. In combination with cisplatin, the approach is synergistic, decreasing glutathione levels and increasing DNA damage compared with cisplatin alone.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},372000,1791102438,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Redox Biology 89 (2026) 103989  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \nRedox-active nitroxides enhance cisplatin efficacy against cervical cancer  \nCarl P. Soltau a,b,1, Debottam Sinhac,1, Lakshita P. Patilc, Philip M. Moseley c, Cassie L. Rayner d, Nigel L. Barnett d, Derek J. Richard b, Steven E. Bottle a, Ian H. Frazer c,  \nAlexander P. Martyne,*   \na School of Chemistry and Physics, Queensland University of Technology, 2 George St, Brisbane, QLD, 4000, Australia  \nb Cancer & Ageing Research Program, Centre for Genomics and Personalised Health, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia  \nc Frazer Institute, Faculty of Medicine, The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia d Clem Jones Centre for Regenerative Medicine, Faculty of Health Sciences and Medicine, Bond University, 14 University Drive, Robina, Gold Coast, QLD, 4226, Australia e Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Building 57, St Lucia, QLD, 4072, Australia  \n\n| A B S T R A C T |\n| --- |\n| Cisplatin remains the primary treatment for most cervical cancer cases, though its clinical efficacy is hindered by dose-dependent toxicity and incurring chemoresistance. The overexpression of the glucocorticoid receptor (GR) and cellular redox state is linked to increased resistance to chemotherapy in cervical cancer. This study explores the combinations of novel steroidal and nitroxide-based treatments to improve the efficacy of cisplatin against cervical cancer. Two lead nitroxidefunctionalised prednisolone hybrids (CS91 and CS187) were identified for their potent anti-proliferative activity in multiple cervical squamous cell carcinoma (SCC) cell lines. These compounds exhibit comparable anti-proliferative activity to the parent nitroxides, while maintaining GR binding capability. When combined with cisplatin, CS91 and CS187 induced a dose-dependent reduction in cell viability across multiple cervical cancer cell lines, which was optimised to preserve above 80 % healthy cell viability but decrease cancer cell viability below 15 %. Mechanistic studies revealed that these compounds raised intracellular reactive oxygen species (ROS) levels, with further enhancement in combination with cisplatin. This combination approach was found to be synergistic, resulting in decreased glutathione (GSH) levels and increased DNA damage compared to cisplatin alone. In summary, nitroxide-based hybrids exhibit potent anti-proliferative effects and potentiatecisplatin efficacy through ROS-mediated mechanisms, offering a promising targeted strategy for cervical cancer treatment. |\n\n1. Introduction  \nCervical cancer is the fourth most common cancer among women and has one of the highest cancer mortality rates worldwide with over half a million new diagnoses and over 300,000 deaths annually [1]. Human papilloma virus (HPV) causes nearly all cervical cancers (99.7 %) and is largely preventable through vaccination and routine screening [2]. Despite widespread vaccination decreasing prevalence [3, 4], limited access to these services in low and middle socioeconomic areas results in late-stage diagnosis and poor treatment outcomes [5]. Early-stage cervical cancer is typically managed with surgical interventions, including hysterectomy or fertility-preserving procedures, while advanced stages require chemotherapy (e.g., cisplatin, 5-fluorouracil), radiotherapy, and immunotherapy [5].  \nCisplatin, the main chemotherapeutic for cervical cancer, works by forming DNA crosslinks, inhibiting replication and transcription, and  \ninducing oxidative stress which leads to apoptosis [6]. Aside from the numerous side effects, resistance to cisplatin in cervical cance","cbCainmnH3KFG84T","https://ap.wps.com/l/cbCainmnH3KFG84T","pdf",7881836,13,"English","# Introduction\n## Cisplatin and chemoresistance in cervical cancer\n## Role of ROS and nitroxide redox activity\n## Study rationale for GR-linked, redox-targeted combinations","[{\"question\":\"Why is cisplatin less effective in cervical cancer over time?\",\"answer\":\"Cisplatin efficacy is hindered by dose-dependent toxicity and chemoresistance. Resistance is associated with factors such as altered uptake, target changes, improved DNA repair or detoxification via elevated cellular thiols like glutathione, and links to glucocorticoid receptor overexpression and cellular redox state.\"},{\"question\":\"What are CS91 and CS187 in this study?\",\"answer\":\"CS91 and CS187 are two nitroxide-functionalised prednisolone hybrid lead compounds. They show potent anti-proliferative activity across multiple cervical squamous cell carcinoma cell lines while maintaining glucocorticoid receptor binding capability.\"},{\"question\":\"How do CS91/CS187 improve cisplatin effects mechanistically?\",\"answer\":\"Mechanistic work indicates these compounds raise intracellular reactive oxygen species levels. In combination with cisplatin, the approach is synergistic, decreasing glutathione levels and increasing DNA damage compared with cisplatin alone.\"}]","Redox-active nitroxides enhance cisplatin efficacy against cervical cancer | PDF",1790193425,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/caf4830dc49a7662492c78df7d3c9d3c.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/526dbe2efd3a87eea40efe669145e545.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76b298e467230a8b8c1268407c08a66d.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a3af0355b58dcec5376d546bed0165a.webp",980,1306]